Preoperative Oral Antibiotics Preparation is Associated With Improved 30-day Outcomes in Elective Colectomy for Ulcerative Colitis | Request PDF
Preoperative Oral Antibiotics Preparation is Associated With Improved 30-day Outcomes in Elective Colectomy for Ulcerative Colitis | Request PDF
Request PDF | Preoperative Oral Antibiotics Preparation is Associated With Improved 30-day Outcomes in Elective Colectomy for Ulcerative Colitis | Background Ulcerative colitis (UC) is characterized by colonic involvement, where the 10-year risk of colectomy remains high at about 20%. The use... | Find, read and cite all the research you need on ResearchGate
·researchgate.net·
Preoperative Oral Antibiotics Preparation is Associated With Improved 30-day Outcomes in Elective Colectomy for Ulcerative Colitis | Request PDF
IMPACT OF ULTRAVIOLET LIGHT DISINFECTION ON REDUCING HOSPITAL-ASSOCIATED INFECTIONS: A SYSTEMATIC REVIEW IN HEALTHCARE ENVIRONMENTS - PubMed
IMPACT OF ULTRAVIOLET LIGHT DISINFECTION ON REDUCING HOSPITAL-ASSOCIATED INFECTIONS: A SYSTEMATIC REVIEW IN HEALTHCARE ENVIRONMENTS - PubMed
UVL disinfection technologies have demonstrated potential in reducing HAIs, particularly when integrated into a comprehensive infection prevention strategy. Their effectiveness, however, varies by application, pathogen type, and healthcare setting. Further research is needed to optimize UVL implemen …
·pubmed.ncbi.nlm.nih.gov·
IMPACT OF ULTRAVIOLET LIGHT DISINFECTION ON REDUCING HOSPITAL-ASSOCIATED INFECTIONS: A SYSTEMATIC REVIEW IN HEALTHCARE ENVIRONMENTS - PubMed
Rapid UV-C sanitisation in a single swipe
Rapid UV-C sanitisation in a single swipe
UV-C light breaks down the DNA of germs, preventing them from replicating in hospital and other settings. Discover more here.
·innovationnewsnetwork.com·
Rapid UV-C sanitisation in a single swipe
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives - PubMed
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives - PubMed
Surfaces contaminated with pathogens pose a significant risk of disease transmission and infection. Alcohol-based disinfectants are widely utilized to decontaminate high-touch areas across various settings. However, their limited antimicrobial activity and the emergence of alcohol-tolerant strains n …
·pubmed.ncbi.nlm.nih.gov·
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives - PubMed
Health Care–Associated Infections and Outcomes at the Intersections
Health Care–Associated Infections and Outcomes at the Intersections
The US Department of Health and Human Services’ Healthy People 2030 initiative calls for reductions in health care–associated infections (HAI) and a strong focus on addressing social determinants of health and eliminating health disparities. Advancing equity in health care to prevent HAI requires a...
·jamanetwork.com·
Health Care–Associated Infections and Outcomes at the Intersections
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives - PubMed
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives - PubMed
Surfaces contaminated with pathogens pose a significant risk of disease transmission and infection. Alcohol-based disinfectants are widely utilized to decontaminate high-touch areas across various settings. However, their limited antimicrobial activity and the emergence of alcohol-tolerant strains n …
·pubmed.ncbi.nlm.nih.gov·
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives - PubMed
Copper oxide-based surfaces can reduce C. diff icile spores
Copper oxide-based surfaces can reduce C. diff icile spores
Copper oxide-containing surfaces significantly reduced Clostridioides difficile spores after 4 hours, according to study findings published in Infection Control & Hospital Epidemiology.
·healio.com·
Copper oxide-based surfaces can reduce C. diff icile spores
STOP-CDI Protocol Significantly Reduces Healthcare-Associated C. diff
STOP-CDI Protocol Significantly Reduces Healthcare-Associated C. diff
The Screening and Targeted Prophylaxis for Clostridioides difficile infection (STOP-CDI) protocol, developed at the University of Pennsylvania, resulted in a substantial reduction in healthcare-associated CDI among patients screened.
·generalsurgerynews.com·
STOP-CDI Protocol Significantly Reduces Healthcare-Associated C. diff
Impact of adjunct bezlotoxumab for preventing Clostridioides difficile infection recurrence in patients post - hematopoietic stem cell transplantation - PubMed
Impact of adjunct bezlotoxumab for preventing Clostridioides difficile infection recurrence in patients post - hematopoietic stem cell transplantation - PubMed
In conclusion, the use of bezlotoxumab did not lead to statistically significant decreases in CDI recurrence in patients post-HSCT. Future studies should be conducted with a larger number of HSCT patients receiving bezlotoxumab to provide supporting evidence of its role in reducing CDI recurrence.
·pubmed.ncbi.nlm.nih.gov·
Impact of adjunct bezlotoxumab for preventing Clostridioides difficile infection recurrence in patients post - hematopoietic stem cell transplantation - PubMed
Does routine use of sporicidal disinfectants for all post-discharge hospital rooms reduce environmental contamination with Clostridioides difficile spores? - PubMed
Does routine use of sporicidal disinfectants for all post-discharge hospital rooms reduce environmental contamination with Clostridioides difficile spores? - PubMed
In a culture survey of 30 U.S. hospitals, rates of Clostridioides difficile spore contamination after cleaning and disinfection of non-C. difficile infection (CDI) rooms were lower in facilities using sporicidal disinfectants in all post-discharge rooms versus only in CDI rooms (3.6% versus 5.1%, re …
·pubmed.ncbi.nlm.nih.gov·
Does routine use of sporicidal disinfectants for all post-discharge hospital rooms reduce environmental contamination with Clostridioides difficile spores? - PubMed
Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control - PubMed
Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control - PubMed
Clostridioides difficile is a major cause of nosocomial diarrhea. As current antibiotic treatment failures and recurrence of infections are highly frequent, alternative strategies are needed for the treatment of this disease. This study explores the use of bacteriocins, specifically lacticin …
·pubmed.ncbi.nlm.nih.gov·
Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control - PubMed
Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients - PubMed
Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients - PubMed
In-hospital incidence of CDI in HSCT patients was significantly decreased with OVP. Randomized controlled trials are needed in this high-risk population to assess the efficacy and risks of OVP for CDI.
·pubmed.ncbi.nlm.nih.gov·
Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients - PubMed
Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control - PubMed
Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control - PubMed
Clostridioides difficile is a major cause of nosocomial diarrhea. As current antibiotic treatment failures and recurrence of infections are highly frequent, alternative strategies are needed for the treatment of this disease. This study explores the use of bacteriocins, specifically lacticin …
·pubmed.ncbi.nlm.nih.gov·
Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control - PubMed
Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease - PubMed
Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease - PubMed
The risk factors for CDI in patients with IBD include younger age, female gender, low body mass index and hypoalbuminaemia, use of thiopurines, antibiotics, and glucocorticosteroids, prolonged hospitalisation, and gastritis and/or duodenitis.
·pubmed.ncbi.nlm.nih.gov·
Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease - PubMed
C Difficile Prevention Therapy Zinplava Discontinued
C Difficile Prevention Therapy Zinplava Discontinued
Zinplava (bezlotoxumab) injection will be discontinued as of January 31, 2025, according to the FDA’s drug shortages tracker.
·infectiousdiseaseadvisor.com·
C Difficile Prevention Therapy Zinplava Discontinued
What the Research Says About Probiotics for IBS
What the Research Says About Probiotics for IBS
Probiotics may help relieve and improve IBS symptoms, like bloating, abdominal pain, and bowel movement irregularity, by balancing the gut’s natural bacteria. Learn more.
·verywellhealth.com·
What the Research Says About Probiotics for IBS
Outbreak containment prevention bundles crucial in nosocomial infection prevention
Outbreak containment prevention bundles crucial in nosocomial infection prevention
Although Candida auris and Clostridioides difficile continue to be dangerous for patients, research published throughout this year has highlighted strides made in outbreak prevention and understanding nosocomial infections.
·healio.com·
Outbreak containment prevention bundles crucial in nosocomial infection prevention
Bifidobacteria antagonize the life cycle of Clostridioides difficile - PubMed
Bifidobacteria antagonize the life cycle of Clostridioides difficile - PubMed
Clostridioides difficile is a spore-forming pathogen capable of causing severe disease in humans. Critical stages in the biological cycle of this microorganism include sporogenesis/germination and toxin production by vegetative cells. Antagonizing these pivotal events could aid in prevention and tre …
·pubmed.ncbi.nlm.nih.gov·
Bifidobacteria antagonize the life cycle of Clostridioides difficile - PubMed